INTRODUCTION
Bipolar Disorder (BD) is a degenerative and chronic illness. In the long term, BD may lead to high morbidity, comorbid mental and physical illnesses, hospitalization, loss of competence, substance abuse, and increased death due to suicides (1) . The recurrence levels are significantly high. Without medication treatment, relapse is over 90% in the 18 months following the manic episodes, and 70% following the depressive episodes. Even if patients are treated with drugs, the 5-year relapse rate exceeds 70% (2) .
BD is an illness that requires a high level of treatment adherence in order to achieve effective treatment as it is a chronic illness requiring continuous treatment. The adherence can be defined as the patient accepting and following recommendations regarding their illness and its treatment. This definition does not just refer to "prescribed drug use," but is a broad definition and also refers to "the treatment adherence, at behavior level, of the patient to all recommendations made by the clinician" (3) . The Word Health Organization (WHO) defines adherence as "the adherence level of behavior displayed by an individual that is receiving treatment, has a special diet, and/or is making changes in their life style in accordance with recommendations made by a health professional" (4).
Nonadherence to treatment in studies ranges between 20% and 70%; the average nonadherence is 40% (6, 7) . This nonadherence is related to unsuccessful treatment results, increased relapse rates (8, 9) , rehospitalization (9,10), suicidal behavior, and increased care costs. Treatment nonadherence to BD is thought to be the main reason of relapse and recurrence (2, 11) . Treatment adherence in a bipolar population is a complex case that is affected by factors related to the health system, individuals that care for the patients, the patient themselves, and numerous illnesses (5, 12) . A relationship has been identified between treatment nonadherence and demographic variables of patients such as age, gender, and ethnicity and illnessspecific characteristics such as the severity of the illness or other additional illnesses. Additionally, some studies report that treatment risks, personal differences in understanding the requirements of medical treatment, unbearable side effects of drugs, complicated drug applications, insufficient knowledge regarding the illness (13) , the fear of being stigmatized (9) , lack of insight (14) , low education level, personality disorders, and abusing additional substances associated with treatment are all factors that have an adverse effect on treatment adherence (2, 15) . The attitude of individuals that suffer from a severe mental illness towards their illness and treatment play an extremely important role in determining the treatment adherence of individuals.
Treatment nonadherence is the most important restriction in transforming treatment success, proven in research studies, into an effective factor in clinical practice (6) . The nonadherence rate is still high, regardless of numerous improvements in medications (16) . The patient's treatment adherence is extremely important in obtaining successful long-term results in BD.
Unfortunately, not many studies have focused on this subject. There are no studies in our country that illustrate the adherence rate. There is only one paper about the attitude of patients.
The purpose of this study is to investigate the treatment adherence of euthymic bipolar patients, who registered in a psychiatric outpatient clinic at least a year ago, and 1) medication treatment adherence level in the last month, 2) the socio-demographic and clinical characteristics that affect adherence, and 3) the number of follow-up examinations within the last year.
METHOD
In previous studies, subjective methods such as examining patient records, investigating repeat prescriptions, views of physicians conducting the treatment on adherence, and self-report of patients regarding their drug use and objective methods such as checking serum and drug levels, measuring drug and metabolite levels in blood, saliva, and urine, and counting the remaining pills in the drug bottles were used. All of Patients were asked the question "How many days have you not taken your medication/medications in the last month" as part of the self-report required to measure the level of medication treatment adherence; in conclusion of their answers, patients were separated into two groups. Those that had not taken their medication or taken it irregularly for less than seven days within the last month were categorized as "treatment adherent," those that had not taken it irregularly between 7 and 14 days were categorized as "partially treatment adherent," and those that had not taken it irregularly for more than 14 days within the last month were categorized as "treatment nonadherent." When analyzing the results for this study, those that fell under the "partially treatment adherent" group were included in the "treatment nonadherent" group. The aim was to clearly identify those that were treatment adherent. In the end, groups that were classified 
RESULTS
For this study, 108 (73.5%) patients were treatment adherent, while 39 (26.5%) patients were treatment nonadherent. 77 of the 147 patients were male, and 70 were female. The number of women were higher in the "treatment adherent" group and the number of men were higher in the "treatment nonadherent" group (p=0.01), (Table 1) .There was no difference between the "treatment adherent" and the "treatment nonadherent" group based on age, marital status, place of residence, employment status, economical status, whether they had social security benefits or not, and whether the uninsured had health care or not (p>0.05), (Table 1) . Treatment adherence changed with the education level (p<0.001).
Those with education exceeding primary school (8 years) were more adherent. There was no difference between groups based on the duration of the illness and the family history in mental illnesses (p>0.05), ( The rate of hospitalization was lower in the treatment adherent group in comparison to the treatment nonadherent group (p<0.05). There was also a difference between groups based on the number of follow-up examinations attended in the last year. The rate of attending follow-up examinations was higher in the adherent group in comparison to the nonadherent group (p<0.001). The insight rate patients had towards their illness was significantly higher in the "treatment adherent" group in comparison to the "treatment nonadherent" group (p<0.001), (Table 2) . In terms of current medication or medication combinations, there was no significant difference between the two groups; in other words, adherence was independent from the current medications prescribed (p>0.05).
The "treatment adherent" group believe that they are more informed about their illness and treatment in comparison to the "treatment nonadherent" group (p<0.001). In the "treatment nonadherent" group, the rate of abandoning medication because patients thought the medication was non-effective (p<0.05) and the rate of abandoning treatment because patients thought they had recovered (p<0.001) were higher. The rate of abandoning treatment because patients thought they had recovered was higher in comparison to the rate of abandoning treatment because patients thought the medication was non-effective (p=0.04, χ 2 =8.64). There was no difference between the two groups based on drug side effects, economical difficulties, transportation issues, negative attitude others have towards taking medication, family negligence, experiencing issues with treatment personnel, and forgetfulness (p>0.05). The number of patients discontent about taking medication was higher in the treatment nonadherent group in comparison to the treatment adherent group (p<0.05) ( Table 3) .
DISCUSSION
In our study, 73.5% of patients were treatment adherent.
According to other subject-related studies, this rate is the expected rate, and it complies with literature. It is an extremely difficult task to determine the rate of treatment adherence of patients accurately. There is no consensus on the subject as to what method should be used to assess adherence (18) . In their study, Lingam et al. identified that the patient self-report, used to evaluate adherence, was the truest subjective method used. It is reported to be highly specific (90%), have low level of sensitivity (approx. 50%).
In their study Lingam et al. classified those that had "not taken more than 30% of their recommended medication in the last month" were treatment nonadherent; in conclusion they indicated that self-report was highly comparable to serum lithium levels, evaluated independently (6). In their self-report study, Scott et al. classified those that "had not taken more than 30% of their prescribed medication in the last month" were partially treatment nonadherent; they concluded that 68% of patients were treatment adherent (12) . In their study, Baldessarini et al. classified those that classified those that "had not forgotten to take a dose of their medication in the last month" as treatment adherent; they concluded that 61.5% of patients were treatment adherent (18) .
The rate of treatment adherence was higher in women in comparison to men. As well as studies that conclude men are less treatment adherent than women (6, 19, 20) , similar to our study, there are studies that conclude women are less treatment adherent (21) , and studies that indicate that gender has no effect on adherence (5,9,22). An important point that needs to be touched upon is that treatment adherence was independent of current medications prescribed. There was no difference between the two groups in terms of taking antipsychotic medication, mood stabilizers, taking two or more mood stabilizers together, and taking mood stabilizers and antipsychotic medication together. In our study, there were no patients taking long-acting antipsychotics. A study indicated that in the group of bipolar patients that use classic long-acting antipsychotics the number of times they were hospitalized was lower that the number of follow-up examinations attended (25) . As well as preventing relapse of bipolar disorder and preventing the illness from getting worse, long-acting antipsychotics can be an effective instrument in coping with treatment adherence (20, 26) . In their study, conducted on a nonadherent group, Savaş et al. reported that long-acting risperidone improve progression by restricting relapse (27) . El-Mallakh emphasized that long-term effective medication preventing relapse of bipolar disorder was also valuable in patient's treatment adherence (2) .
Another important subject is that there was no difference between the two groups based on marital status and whether the patient lived alone or with their family. There are studies that indicate that single patients and patients living alone are less adherent (20) .
In terms of abandoning medication, the leading reasons for abandoning medication were that patients believed they had recovered, and they believed that the treatment was useless. In the nonadherent group, the rate of abandoning medication because they believed they had recovered was higher than the rate of abandoning medication because they believed the medication was not doing them any good. In other words, the reason why patients abandoned the medication was due to the fact that they believed they have fully recovered. They may think this way because of their desire to live in a hypomanic or manic state. This, in turn, complies with the "insufficient insight" information indentified in treatment nonadherent patients. Another reason that disrupts adherence is "being discontent with using medication."
The most important limitation of this study is the fact that other comorbid mental disorders were not excluded from the study.
In conclusion of our study, it is possible to state that some factors, such as a lower education level, insufficient information about the illness, lack of insight, being discontent about using medication, could be changed by educating patients and their close relatives and these were conditions seen mostly is the nonadherent group. In addition, being discontent about using medication seems to be effective in nonadherence, the reasons behind it should be investigated and remedied.
